nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—HTR2A—coronary artery disease	0.126	1	CbGaD
Paroxetine—CYP2C8—Fenofibrate—coronary artery disease	0.0251	0.0507	CbGbCtD
Paroxetine—CYP2B6—Clopidogrel—coronary artery disease	0.023	0.0464	CbGbCtD
Paroxetine—CYP2C8—Gemfibrozil—coronary artery disease	0.0201	0.0405	CbGbCtD
Paroxetine—ABCB1—Ticagrelor—coronary artery disease	0.0191	0.0385	CbGbCtD
Paroxetine—CYP2C9—Fenofibrate—coronary artery disease	0.0175	0.0354	CbGbCtD
Paroxetine—CYP2C8—Clopidogrel—coronary artery disease	0.0174	0.0352	CbGbCtD
Paroxetine—CYP2C8—Pitavastatin—coronary artery disease	0.0152	0.0307	CbGbCtD
Paroxetine—CYP2C9—Gemfibrozil—coronary artery disease	0.014	0.0283	CbGbCtD
Paroxetine—CYP2B6—Simvastatin—coronary artery disease	0.0138	0.0278	CbGbCtD
Paroxetine—CYP2B6—Atorvastatin—coronary artery disease	0.0123	0.0248	CbGbCtD
Paroxetine—CYP2C9—Clopidogrel—coronary artery disease	0.0122	0.0245	CbGbCtD
Paroxetine—ABCB1—Perindopril—coronary artery disease	0.0118	0.0238	CbGbCtD
Paroxetine—ABCB1—Clopidogrel—coronary artery disease	0.0118	0.0238	CbGbCtD
Paroxetine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0109	0.0221	CbGbCtD
Paroxetine—CYP2C9—Pitavastatin—coronary artery disease	0.0106	0.0214	CbGbCtD
Paroxetine—CYP2C8—Simvastatin—coronary artery disease	0.0104	0.0211	CbGbCtD
Paroxetine—CYP2C9—Valsartan—coronary artery disease	0.0103	0.0208	CbGbCtD
Paroxetine—ABCB1—Pitavastatin—coronary artery disease	0.0103	0.0208	CbGbCtD
Paroxetine—ABCB1—Telmisartan—coronary artery disease	0.0103	0.0208	CbGbCtD
Paroxetine—CYP2C8—Pravastatin—coronary artery disease	0.0102	0.0206	CbGbCtD
Paroxetine—CYP2C8—Lovastatin—coronary artery disease	0.0102	0.0206	CbGbCtD
Paroxetine—ABCB1—Enalapril—coronary artery disease	0.00977	0.0197	CbGbCtD
Paroxetine—ABCB1—Lisinopril—coronary artery disease	0.00977	0.0197	CbGbCtD
Paroxetine—CYP2C8—Atorvastatin—coronary artery disease	0.0093	0.0188	CbGbCtD
Paroxetine—CYP2C8—Losartan—coronary artery disease	0.00851	0.0172	CbGbCtD
Paroxetine—CYP2D6—Niacin—coronary artery disease	0.00842	0.017	CbGbCtD
Paroxetine—ABCB1—Timolol—coronary artery disease	0.00831	0.0168	CbGbCtD
Paroxetine—CYP2C9—Rosuvastatin—coronary artery disease	0.00783	0.0158	CbGbCtD
Paroxetine—CYP2D6—Timolol—coronary artery disease	0.00783	0.0158	CbGbCtD
Paroxetine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00763	0.0154	CbGbCtD
Paroxetine—ABCB1—Ezetimibe—coronary artery disease	0.0076	0.0153	CbGbCtD
Paroxetine—TACR1—vagus nerve—coronary artery disease	0.00755	0.199	CbGeAlD
Paroxetine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00741	0.0149	CbGbCtD
Paroxetine—ABCB1—Captopril—coronary artery disease	0.00731	0.0148	CbGbCtD
Paroxetine—CYP2C9—Simvastatin—coronary artery disease	0.00728	0.0147	CbGbCtD
Paroxetine—CYP2C9—Pravastatin—coronary artery disease	0.00712	0.0144	CbGbCtD
Paroxetine—CYP2C9—Lovastatin—coronary artery disease	0.00712	0.0144	CbGbCtD
Paroxetine—ABCB1—Simvastatin—coronary artery disease	0.00706	0.0143	CbGbCtD
Paroxetine—ABCB1—Pravastatin—coronary artery disease	0.00691	0.0139	CbGbCtD
Paroxetine—ABCB1—Lovastatin—coronary artery disease	0.00691	0.0139	CbGbCtD
Paroxetine—CYP2D6—Captopril—coronary artery disease	0.00689	0.0139	CbGbCtD
Paroxetine—CYP2D6—Simvastatin—coronary artery disease	0.00666	0.0134	CbGbCtD
Paroxetine—CYP2D6—Lovastatin—coronary artery disease	0.00651	0.0131	CbGbCtD
Paroxetine—CYP2D6—Pravastatin—coronary artery disease	0.00651	0.0131	CbGbCtD
Paroxetine—CYP2C9—Atorvastatin—coronary artery disease	0.00649	0.0131	CbGbCtD
Paroxetine—ABCB1—Atorvastatin—coronary artery disease	0.0063	0.0127	CbGbCtD
Paroxetine—CYP2C9—Losartan—coronary artery disease	0.00593	0.012	CbGbCtD
Paroxetine—CYP2D6—Atorvastatin—coronary artery disease	0.00593	0.012	CbGbCtD
Paroxetine—CYP2C9—cardial valve—coronary artery disease	0.00587	0.155	CbGeAlD
Paroxetine—ABCB1—Losartan—coronary artery disease	0.00576	0.0116	CbGbCtD
Paroxetine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00317	0.0834	CbGeAlD
Paroxetine—HTR2A—arteriole—coronary artery disease	0.00299	0.0787	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—coronary artery disease	0.00213	0.0561	CbGeAlD
Paroxetine—HTR2A—pulmonary artery—coronary artery disease	0.00196	0.0516	CbGeAlD
Paroxetine—HTR2A—sympathetic nervous system—coronary artery disease	0.0019	0.0502	CbGeAlD
Paroxetine—HTR2A—vagus nerve—coronary artery disease	0.00184	0.0486	CbGeAlD
Paroxetine—HTR2A—vein—coronary artery disease	0.00178	0.0469	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—coronary artery disease	0.00128	0.0337	CbGeAlD
Paroxetine—TACR1—blood—coronary artery disease	0.000817	0.0215	CbGeAlD
Paroxetine—HTR2A—artery—coronary artery disease	0.000725	0.0191	CbGeAlD
Paroxetine—HTR2A—endothelium—coronary artery disease	0.000613	0.0161	CbGeAlD
Paroxetine—CHRM2—heart—coronary artery disease	0.000552	0.0146	CbGeAlD
Paroxetine—CHRM2—cardiovascular system—coronary artery disease	0.000521	0.0137	CbGeAlD
Paroxetine—CHRM1—cardiovascular system—coronary artery disease	0.000474	0.0125	CbGeAlD
Paroxetine—SLC6A4—blood—coronary artery disease	0.000377	0.00993	CbGeAlD
Paroxetine—CYP2B6—heart—coronary artery disease	0.000327	0.00863	CbGeAlD
Paroxetine—CYP2C9—heart—coronary artery disease	0.000324	0.00855	CbGeAlD
Paroxetine—CYP2B6—cardiovascular system—coronary artery disease	0.000309	0.00814	CbGeAlD
Paroxetine—CYP2C9—cardiovascular system—coronary artery disease	0.000306	0.00807	CbGeAlD
Paroxetine—CYP2C8—blood—coronary artery disease	0.000272	0.00718	CbGeAlD
Paroxetine—HTR2A—heart—coronary artery disease	0.000267	0.00704	CbGeAlD
Paroxetine—HTR2A—cardiovascular system—coronary artery disease	0.000252	0.00664	CbGeAlD
Paroxetine—CYP2B6—blood—coronary artery disease	0.000244	0.00644	CbGeAlD
Paroxetine—CYP2C9—blood—coronary artery disease	0.000242	0.00638	CbGeAlD
Paroxetine—HTR2A—blood—coronary artery disease	0.000199	0.00525	CbGeAlD
Paroxetine—CYP2D6—blood—coronary artery disease	0.000182	0.00479	CbGeAlD
Paroxetine—ABCB1—heart—coronary artery disease	0.000175	0.00461	CbGeAlD
Paroxetine—ABCB1—cardiovascular system—coronary artery disease	0.000165	0.00435	CbGeAlD
Paroxetine—ABCB1—blood—coronary artery disease	0.000131	0.00344	CbGeAlD
Paroxetine—Asthenia—Niacin—coronary artery disease	3.03e-05	0.000136	CcSEcCtD
Paroxetine—Fatigue—Losartan—coronary artery disease	3.03e-05	0.000136	CcSEcCtD
Paroxetine—Headache—Ezetimibe—coronary artery disease	3.02e-05	0.000136	CcSEcCtD
Paroxetine—Malaise—Lisinopril—coronary artery disease	3.02e-05	0.000136	CcSEcCtD
Paroxetine—Anaphylactic shock—Ramipril—coronary artery disease	3.02e-05	0.000135	CcSEcCtD
Paroxetine—Oedema—Ramipril—coronary artery disease	3.02e-05	0.000135	CcSEcCtD
Paroxetine—Vertigo—Lisinopril—coronary artery disease	3.01e-05	0.000135	CcSEcCtD
Paroxetine—Dry mouth—Timolol—coronary artery disease	3.01e-05	0.000135	CcSEcCtD
Paroxetine—Pain—Losartan—coronary artery disease	3.01e-05	0.000135	CcSEcCtD
Paroxetine—Constipation—Losartan—coronary artery disease	3.01e-05	0.000135	CcSEcCtD
Paroxetine—Syncope—Lisinopril—coronary artery disease	3e-05	0.000135	CcSEcCtD
Paroxetine—Vomiting—Eplerenone—coronary artery disease	3e-05	0.000135	CcSEcCtD
Paroxetine—Feeling abnormal—Furosemide—coronary artery disease	3e-05	0.000135	CcSEcCtD
Paroxetine—Leukopenia—Lisinopril—coronary artery disease	3e-05	0.000135	CcSEcCtD
Paroxetine—Nausea—Fenofibrate—coronary artery disease	2.99e-05	0.000135	CcSEcCtD
Paroxetine—Pruritus—Niacin—coronary artery disease	2.99e-05	0.000134	CcSEcCtD
Paroxetine—Asthenia—Pravastatin—coronary artery disease	2.99e-05	0.000134	CcSEcCtD
Paroxetine—Gastrointestinal pain—Furosemide—coronary artery disease	2.98e-05	0.000134	CcSEcCtD
Paroxetine—Rash—Eplerenone—coronary artery disease	2.98e-05	0.000134	CcSEcCtD
Paroxetine—Urticaria—Perindopril—coronary artery disease	2.98e-05	0.000134	CcSEcCtD
Paroxetine—Hypersensitivity—Trandolapril—coronary artery disease	2.98e-05	0.000134	CcSEcCtD
Paroxetine—Dermatitis—Eplerenone—coronary artery disease	2.98e-05	0.000134	CcSEcCtD
Paroxetine—Diarrhoea—Valsartan—coronary artery disease	2.98e-05	0.000134	CcSEcCtD
Paroxetine—Confusional state—Timolol—coronary artery disease	2.97e-05	0.000134	CcSEcCtD
Paroxetine—Shock—Ramipril—coronary artery disease	2.97e-05	0.000133	CcSEcCtD
Paroxetine—Hypersensitivity—Enalapril—coronary artery disease	2.97e-05	0.000133	CcSEcCtD
Paroxetine—Abdominal pain—Perindopril—coronary artery disease	2.96e-05	0.000133	CcSEcCtD
Paroxetine—Body temperature increased—Perindopril—coronary artery disease	2.96e-05	0.000133	CcSEcCtD
Paroxetine—Palpitations—Lisinopril—coronary artery disease	2.96e-05	0.000133	CcSEcCtD
Paroxetine—Diarrhoea—Olmesartan—coronary artery disease	2.96e-05	0.000133	CcSEcCtD
Paroxetine—Headache—Eplerenone—coronary artery disease	2.96e-05	0.000133	CcSEcCtD
Paroxetine—Nervous system disorder—Ramipril—coronary artery disease	2.96e-05	0.000133	CcSEcCtD
Paroxetine—Thrombocytopenia—Ramipril—coronary artery disease	2.95e-05	0.000133	CcSEcCtD
Paroxetine—Anaphylactic shock—Timolol—coronary artery disease	2.95e-05	0.000132	CcSEcCtD
Paroxetine—Oedema—Timolol—coronary artery disease	2.95e-05	0.000132	CcSEcCtD
Paroxetine—Pruritus—Pravastatin—coronary artery disease	2.95e-05	0.000132	CcSEcCtD
Paroxetine—Loss of consciousness—Lisinopril—coronary artery disease	2.95e-05	0.000132	CcSEcCtD
Paroxetine—Nausea—Clopidogrel—coronary artery disease	2.94e-05	0.000132	CcSEcCtD
Paroxetine—Tachycardia—Ramipril—coronary artery disease	2.94e-05	0.000132	CcSEcCtD
Paroxetine—Skin disorder—Ramipril—coronary artery disease	2.93e-05	0.000132	CcSEcCtD
Paroxetine—Infection—Timolol—coronary artery disease	2.93e-05	0.000132	CcSEcCtD
Paroxetine—Vomiting—Simvastatin—coronary artery disease	2.93e-05	0.000132	CcSEcCtD
Paroxetine—Hypersensitivity—Telmisartan—coronary artery disease	2.93e-05	0.000131	CcSEcCtD
Paroxetine—Cough—Lisinopril—coronary artery disease	2.92e-05	0.000131	CcSEcCtD
Paroxetine—Nausea—Lovastatin—coronary artery disease	2.92e-05	0.000131	CcSEcCtD
Paroxetine—Hyperhidrosis—Ramipril—coronary artery disease	2.92e-05	0.000131	CcSEcCtD
Paroxetine—Rash—Simvastatin—coronary artery disease	2.9e-05	0.00013	CcSEcCtD
Paroxetine—Dermatitis—Simvastatin—coronary artery disease	2.9e-05	0.00013	CcSEcCtD
Paroxetine—Asthenia—Trandolapril—coronary artery disease	2.9e-05	0.00013	CcSEcCtD
Paroxetine—Shock—Timolol—coronary artery disease	2.9e-05	0.00013	CcSEcCtD
Paroxetine—Feeling abnormal—Losartan—coronary artery disease	2.9e-05	0.00013	CcSEcCtD
Paroxetine—Urticaria—Furosemide—coronary artery disease	2.9e-05	0.00013	CcSEcCtD
Paroxetine—Diarrhoea—Niacin—coronary artery disease	2.89e-05	0.00013	CcSEcCtD
Paroxetine—Nervous system disorder—Timolol—coronary artery disease	2.89e-05	0.00013	CcSEcCtD
Paroxetine—Asthenia—Enalapril—coronary artery disease	2.89e-05	0.00013	CcSEcCtD
Paroxetine—Headache—Simvastatin—coronary artery disease	2.88e-05	0.00013	CcSEcCtD
Paroxetine—Abdominal pain—Furosemide—coronary artery disease	2.88e-05	0.000129	CcSEcCtD
Paroxetine—Body temperature increased—Furosemide—coronary artery disease	2.88e-05	0.000129	CcSEcCtD
Paroxetine—Gastrointestinal pain—Losartan—coronary artery disease	2.88e-05	0.000129	CcSEcCtD
Paroxetine—Dizziness—Valsartan—coronary artery disease	2.88e-05	0.000129	CcSEcCtD
Paroxetine—Nausea—Ezetimibe—coronary artery disease	2.87e-05	0.000129	CcSEcCtD
Paroxetine—Skin disorder—Timolol—coronary artery disease	2.86e-05	0.000129	CcSEcCtD
Paroxetine—Dizziness—Olmesartan—coronary artery disease	2.86e-05	0.000129	CcSEcCtD
Paroxetine—Pruritus—Trandolapril—coronary artery disease	2.86e-05	0.000129	CcSEcCtD
Paroxetine—Myalgia—Lisinopril—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Chest pain—Lisinopril—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Arthralgia—Lisinopril—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Hyperhidrosis—Timolol—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Asthenia—Telmisartan—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Pruritus—Enalapril—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Diarrhoea—Pravastatin—coronary artery disease	2.85e-05	0.000128	CcSEcCtD
Paroxetine—Anxiety—Lisinopril—coronary artery disease	2.84e-05	0.000128	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.83e-05	0.000127	CcSEcCtD
Paroxetine—Discomfort—Lisinopril—coronary artery disease	2.82e-05	0.000127	CcSEcCtD
Paroxetine—Hypotension—Ramipril—coronary artery disease	2.82e-05	0.000127	CcSEcCtD
Paroxetine—Pruritus—Telmisartan—coronary artery disease	2.81e-05	0.000126	CcSEcCtD
Paroxetine—Nausea—Eplerenone—coronary artery disease	2.81e-05	0.000126	CcSEcCtD
Paroxetine—Dizziness—Niacin—coronary artery disease	2.8e-05	0.000126	CcSEcCtD
Paroxetine—Urticaria—Losartan—coronary artery disease	2.79e-05	0.000126	CcSEcCtD
Paroxetine—Dry mouth—Lisinopril—coronary artery disease	2.79e-05	0.000125	CcSEcCtD
Paroxetine—Body temperature increased—Losartan—coronary artery disease	2.78e-05	0.000125	CcSEcCtD
Paroxetine—Abdominal pain—Losartan—coronary artery disease	2.78e-05	0.000125	CcSEcCtD
Paroxetine—Asthenia—Captopril—coronary artery disease	2.77e-05	0.000124	CcSEcCtD
Paroxetine—Diarrhoea—Trandolapril—coronary artery disease	2.77e-05	0.000124	CcSEcCtD
Paroxetine—Vomiting—Valsartan—coronary artery disease	2.76e-05	0.000124	CcSEcCtD
Paroxetine—Confusional state—Lisinopril—coronary artery disease	2.76e-05	0.000124	CcSEcCtD
Paroxetine—Diarrhoea—Enalapril—coronary artery disease	2.75e-05	0.000124	CcSEcCtD
Paroxetine—Hypotension—Timolol—coronary artery disease	2.75e-05	0.000124	CcSEcCtD
Paroxetine—Dizziness—Pravastatin—coronary artery disease	2.75e-05	0.000124	CcSEcCtD
Paroxetine—Vomiting—Olmesartan—coronary artery disease	2.75e-05	0.000124	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.75e-05	0.000123	CcSEcCtD
Paroxetine—Rash—Valsartan—coronary artery disease	2.74e-05	0.000123	CcSEcCtD
Paroxetine—Dermatitis—Valsartan—coronary artery disease	2.74e-05	0.000123	CcSEcCtD
Paroxetine—Nausea—Simvastatin—coronary artery disease	2.73e-05	0.000123	CcSEcCtD
Paroxetine—Anaphylactic shock—Lisinopril—coronary artery disease	2.73e-05	0.000123	CcSEcCtD
Paroxetine—Oedema—Lisinopril—coronary artery disease	2.73e-05	0.000123	CcSEcCtD
Paroxetine—Pruritus—Captopril—coronary artery disease	2.73e-05	0.000123	CcSEcCtD
Paroxetine—Rash—Olmesartan—coronary artery disease	2.73e-05	0.000123	CcSEcCtD
Paroxetine—Insomnia—Ramipril—coronary artery disease	2.73e-05	0.000123	CcSEcCtD
Paroxetine—Dermatitis—Olmesartan—coronary artery disease	2.73e-05	0.000122	CcSEcCtD
Paroxetine—Headache—Valsartan—coronary artery disease	2.72e-05	0.000122	CcSEcCtD
Paroxetine—Diarrhoea—Telmisartan—coronary artery disease	2.72e-05	0.000122	CcSEcCtD
Paroxetine—Infection—Lisinopril—coronary artery disease	2.72e-05	0.000122	CcSEcCtD
Paroxetine—Headache—Olmesartan—coronary artery disease	2.71e-05	0.000122	CcSEcCtD
Paroxetine—Paraesthesia—Ramipril—coronary artery disease	2.71e-05	0.000122	CcSEcCtD
Paroxetine—Shock—Lisinopril—coronary artery disease	2.69e-05	0.000121	CcSEcCtD
Paroxetine—Asthenia—Perindopril—coronary artery disease	2.69e-05	0.000121	CcSEcCtD
Paroxetine—Dyspnoea—Ramipril—coronary artery disease	2.69e-05	0.000121	CcSEcCtD
Paroxetine—Vomiting—Niacin—coronary artery disease	2.69e-05	0.000121	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Timolol—coronary artery disease	2.69e-05	0.000121	CcSEcCtD
Paroxetine—Hypersensitivity—Furosemide—coronary artery disease	2.69e-05	0.000121	CcSEcCtD
Paroxetine—Somnolence—Ramipril—coronary artery disease	2.68e-05	0.00012	CcSEcCtD
Paroxetine—Thrombocytopenia—Lisinopril—coronary artery disease	2.68e-05	0.00012	CcSEcCtD
Paroxetine—Dizziness—Trandolapril—coronary artery disease	2.67e-05	0.00012	CcSEcCtD
Paroxetine—Tachycardia—Lisinopril—coronary artery disease	2.67e-05	0.00012	CcSEcCtD
Paroxetine—Insomnia—Timolol—coronary artery disease	2.67e-05	0.00012	CcSEcCtD
Paroxetine—Rash—Niacin—coronary artery disease	2.67e-05	0.00012	CcSEcCtD
Paroxetine—Dermatitis—Niacin—coronary artery disease	2.66e-05	0.00012	CcSEcCtD
Paroxetine—Dizziness—Enalapril—coronary artery disease	2.66e-05	0.00012	CcSEcCtD
Paroxetine—Skin disorder—Lisinopril—coronary artery disease	2.66e-05	0.000119	CcSEcCtD
Paroxetine—Dyspepsia—Ramipril—coronary artery disease	2.65e-05	0.000119	CcSEcCtD
Paroxetine—Pruritus—Perindopril—coronary artery disease	2.65e-05	0.000119	CcSEcCtD
Paroxetine—Headache—Niacin—coronary artery disease	2.65e-05	0.000119	CcSEcCtD
Paroxetine—Paraesthesia—Timolol—coronary artery disease	2.65e-05	0.000119	CcSEcCtD
Paroxetine—Vomiting—Pravastatin—coronary artery disease	2.65e-05	0.000119	CcSEcCtD
Paroxetine—Hyperhidrosis—Lisinopril—coronary artery disease	2.64e-05	0.000119	CcSEcCtD
Paroxetine—Diarrhoea—Captopril—coronary artery disease	2.64e-05	0.000119	CcSEcCtD
Paroxetine—Dyspnoea—Timolol—coronary artery disease	2.63e-05	0.000118	CcSEcCtD
Paroxetine—Dizziness—Telmisartan—coronary artery disease	2.63e-05	0.000118	CcSEcCtD
Paroxetine—Rash—Pravastatin—coronary artery disease	2.62e-05	0.000118	CcSEcCtD
Paroxetine—Dermatitis—Pravastatin—coronary artery disease	2.62e-05	0.000118	CcSEcCtD
Paroxetine—Decreased appetite—Ramipril—coronary artery disease	2.62e-05	0.000118	CcSEcCtD
Paroxetine—Somnolence—Timolol—coronary artery disease	2.62e-05	0.000118	CcSEcCtD
Paroxetine—Asthenia—Furosemide—coronary artery disease	2.62e-05	0.000118	CcSEcCtD
Paroxetine—Headache—Pravastatin—coronary artery disease	2.61e-05	0.000117	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Ramipril—coronary artery disease	2.6e-05	0.000117	CcSEcCtD
Paroxetine—Fatigue—Ramipril—coronary artery disease	2.6e-05	0.000117	CcSEcCtD
Paroxetine—Dyspepsia—Timolol—coronary artery disease	2.59e-05	0.000117	CcSEcCtD
Paroxetine—Hypersensitivity—Losartan—coronary artery disease	2.59e-05	0.000116	CcSEcCtD
Paroxetine—Nausea—Valsartan—coronary artery disease	2.58e-05	0.000116	CcSEcCtD
Paroxetine—Pruritus—Furosemide—coronary artery disease	2.58e-05	0.000116	CcSEcCtD
Paroxetine—Constipation—Ramipril—coronary artery disease	2.58e-05	0.000116	CcSEcCtD
Paroxetine—Nausea—Olmesartan—coronary artery disease	2.57e-05	0.000115	CcSEcCtD
Paroxetine—Vomiting—Trandolapril—coronary artery disease	2.57e-05	0.000115	CcSEcCtD
Paroxetine—Diarrhoea—Perindopril—coronary artery disease	2.57e-05	0.000115	CcSEcCtD
Paroxetine—Decreased appetite—Timolol—coronary artery disease	2.56e-05	0.000115	CcSEcCtD
Paroxetine—Vomiting—Enalapril—coronary artery disease	2.56e-05	0.000115	CcSEcCtD
Paroxetine—Hypotension—Lisinopril—coronary artery disease	2.56e-05	0.000115	CcSEcCtD
Paroxetine—Dizziness—Captopril—coronary artery disease	2.55e-05	0.000115	CcSEcCtD
Paroxetine—Rash—Trandolapril—coronary artery disease	2.55e-05	0.000115	CcSEcCtD
Paroxetine—Dermatitis—Trandolapril—coronary artery disease	2.55e-05	0.000114	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Timolol—coronary artery disease	2.54e-05	0.000114	CcSEcCtD
Paroxetine—Fatigue—Timolol—coronary artery disease	2.54e-05	0.000114	CcSEcCtD
Paroxetine—Rash—Enalapril—coronary artery disease	2.54e-05	0.000114	CcSEcCtD
Paroxetine—Dermatitis—Enalapril—coronary artery disease	2.54e-05	0.000114	CcSEcCtD
Paroxetine—Headache—Trandolapril—coronary artery disease	2.53e-05	0.000114	CcSEcCtD
Paroxetine—Vomiting—Telmisartan—coronary artery disease	2.52e-05	0.000113	CcSEcCtD
Paroxetine—Asthenia—Losartan—coronary artery disease	2.52e-05	0.000113	CcSEcCtD
Paroxetine—Headache—Enalapril—coronary artery disease	2.52e-05	0.000113	CcSEcCtD
Paroxetine—Pain—Timolol—coronary artery disease	2.52e-05	0.000113	CcSEcCtD
Paroxetine—Nausea—Niacin—coronary artery disease	2.51e-05	0.000113	CcSEcCtD
Paroxetine—Rash—Telmisartan—coronary artery disease	2.5e-05	0.000113	CcSEcCtD
Paroxetine—Dermatitis—Telmisartan—coronary artery disease	2.5e-05	0.000112	CcSEcCtD
Paroxetine—Diarrhoea—Furosemide—coronary artery disease	2.49e-05	0.000112	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.49e-05	0.000112	CcSEcCtD
Paroxetine—Pruritus—Losartan—coronary artery disease	2.49e-05	0.000112	CcSEcCtD
Paroxetine—Headache—Telmisartan—coronary artery disease	2.49e-05	0.000112	CcSEcCtD
Paroxetine—Feeling abnormal—Ramipril—coronary artery disease	2.48e-05	0.000112	CcSEcCtD
Paroxetine—Dizziness—Perindopril—coronary artery disease	2.48e-05	0.000111	CcSEcCtD
Paroxetine—Insomnia—Lisinopril—coronary artery disease	2.47e-05	0.000111	CcSEcCtD
Paroxetine—Nausea—Pravastatin—coronary artery disease	2.47e-05	0.000111	CcSEcCtD
Paroxetine—Gastrointestinal pain—Ramipril—coronary artery disease	2.47e-05	0.000111	CcSEcCtD
Paroxetine—Paraesthesia—Lisinopril—coronary artery disease	2.46e-05	0.00011	CcSEcCtD
Paroxetine—Vomiting—Captopril—coronary artery disease	2.46e-05	0.00011	CcSEcCtD
Paroxetine—Dyspnoea—Lisinopril—coronary artery disease	2.44e-05	0.00011	CcSEcCtD
Paroxetine—Rash—Captopril—coronary artery disease	2.43e-05	0.000109	CcSEcCtD
Paroxetine—Dermatitis—Captopril—coronary artery disease	2.43e-05	0.000109	CcSEcCtD
Paroxetine—Somnolence—Lisinopril—coronary artery disease	2.43e-05	0.000109	CcSEcCtD
Paroxetine—Feeling abnormal—Timolol—coronary artery disease	2.43e-05	0.000109	CcSEcCtD
Paroxetine—Headache—Captopril—coronary artery disease	2.42e-05	0.000109	CcSEcCtD
Paroxetine—Gastrointestinal pain—Timolol—coronary artery disease	2.41e-05	0.000108	CcSEcCtD
Paroxetine—Dizziness—Furosemide—coronary artery disease	2.41e-05	0.000108	CcSEcCtD
Paroxetine—Dyspepsia—Lisinopril—coronary artery disease	2.41e-05	0.000108	CcSEcCtD
Paroxetine—Diarrhoea—Losartan—coronary artery disease	2.41e-05	0.000108	CcSEcCtD
Paroxetine—Nausea—Trandolapril—coronary artery disease	2.4e-05	0.000108	CcSEcCtD
Paroxetine—Urticaria—Ramipril—coronary artery disease	2.4e-05	0.000108	CcSEcCtD
Paroxetine—Nausea—Enalapril—coronary artery disease	2.39e-05	0.000107	CcSEcCtD
Paroxetine—Vomiting—Perindopril—coronary artery disease	2.38e-05	0.000107	CcSEcCtD
Paroxetine—Abdominal pain—Ramipril—coronary artery disease	2.38e-05	0.000107	CcSEcCtD
Paroxetine—Body temperature increased—Ramipril—coronary artery disease	2.38e-05	0.000107	CcSEcCtD
Paroxetine—Decreased appetite—Lisinopril—coronary artery disease	2.38e-05	0.000107	CcSEcCtD
Paroxetine—Rash—Perindopril—coronary artery disease	2.36e-05	0.000106	CcSEcCtD
Paroxetine—Dermatitis—Perindopril—coronary artery disease	2.36e-05	0.000106	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.36e-05	0.000106	CcSEcCtD
Paroxetine—Nausea—Telmisartan—coronary artery disease	2.36e-05	0.000106	CcSEcCtD
Paroxetine—Fatigue—Lisinopril—coronary artery disease	2.36e-05	0.000106	CcSEcCtD
Paroxetine—Headache—Perindopril—coronary artery disease	2.35e-05	0.000106	CcSEcCtD
Paroxetine—Urticaria—Timolol—coronary artery disease	2.34e-05	0.000105	CcSEcCtD
Paroxetine—Constipation—Lisinopril—coronary artery disease	2.34e-05	0.000105	CcSEcCtD
Paroxetine—Pain—Lisinopril—coronary artery disease	2.34e-05	0.000105	CcSEcCtD
Paroxetine—Body temperature increased—Timolol—coronary artery disease	2.33e-05	0.000105	CcSEcCtD
Paroxetine—Abdominal pain—Timolol—coronary artery disease	2.33e-05	0.000105	CcSEcCtD
Paroxetine—Dizziness—Losartan—coronary artery disease	2.33e-05	0.000104	CcSEcCtD
Paroxetine—Vomiting—Furosemide—coronary artery disease	2.32e-05	0.000104	CcSEcCtD
Paroxetine—Rash—Furosemide—coronary artery disease	2.3e-05	0.000103	CcSEcCtD
Paroxetine—Dermatitis—Furosemide—coronary artery disease	2.3e-05	0.000103	CcSEcCtD
Paroxetine—Nausea—Captopril—coronary artery disease	2.29e-05	0.000103	CcSEcCtD
Paroxetine—Headache—Furosemide—coronary artery disease	2.28e-05	0.000103	CcSEcCtD
Paroxetine—Feeling abnormal—Lisinopril—coronary artery disease	2.25e-05	0.000101	CcSEcCtD
Paroxetine—Gastrointestinal pain—Lisinopril—coronary artery disease	2.24e-05	0.0001	CcSEcCtD
Paroxetine—Vomiting—Losartan—coronary artery disease	2.24e-05	0.0001	CcSEcCtD
Paroxetine—Nausea—Perindopril—coronary artery disease	2.23e-05	0.0001	CcSEcCtD
Paroxetine—Hypersensitivity—Ramipril—coronary artery disease	2.22e-05	9.98e-05	CcSEcCtD
Paroxetine—Rash—Losartan—coronary artery disease	2.22e-05	9.96e-05	CcSEcCtD
Paroxetine—Dermatitis—Losartan—coronary artery disease	2.22e-05	9.95e-05	CcSEcCtD
Paroxetine—Headache—Losartan—coronary artery disease	2.2e-05	9.9e-05	CcSEcCtD
Paroxetine—Urticaria—Lisinopril—coronary artery disease	2.17e-05	9.76e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Timolol—coronary artery disease	2.17e-05	9.76e-05	CcSEcCtD
Paroxetine—Nausea—Furosemide—coronary artery disease	2.16e-05	9.73e-05	CcSEcCtD
Paroxetine—Asthenia—Ramipril—coronary artery disease	2.16e-05	9.72e-05	CcSEcCtD
Paroxetine—Abdominal pain—Lisinopril—coronary artery disease	2.16e-05	9.71e-05	CcSEcCtD
Paroxetine—Body temperature increased—Lisinopril—coronary artery disease	2.16e-05	9.71e-05	CcSEcCtD
Paroxetine—Pruritus—Ramipril—coronary artery disease	2.13e-05	9.59e-05	CcSEcCtD
Paroxetine—Asthenia—Timolol—coronary artery disease	2.12e-05	9.5e-05	CcSEcCtD
Paroxetine—Nausea—Losartan—coronary artery disease	2.09e-05	9.39e-05	CcSEcCtD
Paroxetine—Pruritus—Timolol—coronary artery disease	2.09e-05	9.37e-05	CcSEcCtD
Paroxetine—Diarrhoea—Ramipril—coronary artery disease	2.06e-05	9.27e-05	CcSEcCtD
Paroxetine—Diarrhoea—Timolol—coronary artery disease	2.02e-05	9.06e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Lisinopril—coronary artery disease	2.01e-05	9.05e-05	CcSEcCtD
Paroxetine—Dizziness—Ramipril—coronary artery disease	1.99e-05	8.96e-05	CcSEcCtD
Paroxetine—Asthenia—Lisinopril—coronary artery disease	1.96e-05	8.82e-05	CcSEcCtD
Paroxetine—Dizziness—Timolol—coronary artery disease	1.95e-05	8.76e-05	CcSEcCtD
Paroxetine—Pruritus—Lisinopril—coronary artery disease	1.93e-05	8.69e-05	CcSEcCtD
Paroxetine—Vomiting—Ramipril—coronary artery disease	1.92e-05	8.61e-05	CcSEcCtD
Paroxetine—Rash—Ramipril—coronary artery disease	1.9e-05	8.54e-05	CcSEcCtD
Paroxetine—Dermatitis—Ramipril—coronary artery disease	1.9e-05	8.54e-05	CcSEcCtD
Paroxetine—Headache—Ramipril—coronary artery disease	1.89e-05	8.49e-05	CcSEcCtD
Paroxetine—Vomiting—Timolol—coronary artery disease	1.87e-05	8.42e-05	CcSEcCtD
Paroxetine—Diarrhoea—Lisinopril—coronary artery disease	1.87e-05	8.41e-05	CcSEcCtD
Paroxetine—Rash—Timolol—coronary artery disease	1.86e-05	8.35e-05	CcSEcCtD
Paroxetine—Dermatitis—Timolol—coronary artery disease	1.86e-05	8.34e-05	CcSEcCtD
Paroxetine—Headache—Timolol—coronary artery disease	1.85e-05	8.3e-05	CcSEcCtD
Paroxetine—Dizziness—Lisinopril—coronary artery disease	1.81e-05	8.13e-05	CcSEcCtD
Paroxetine—Nausea—Ramipril—coronary artery disease	1.79e-05	8.05e-05	CcSEcCtD
Paroxetine—Nausea—Timolol—coronary artery disease	1.75e-05	7.87e-05	CcSEcCtD
Paroxetine—Vomiting—Lisinopril—coronary artery disease	1.74e-05	7.81e-05	CcSEcCtD
Paroxetine—Rash—Lisinopril—coronary artery disease	1.72e-05	7.75e-05	CcSEcCtD
Paroxetine—Dermatitis—Lisinopril—coronary artery disease	1.72e-05	7.74e-05	CcSEcCtD
Paroxetine—Headache—Lisinopril—coronary artery disease	1.71e-05	7.7e-05	CcSEcCtD
Paroxetine—Nausea—Lisinopril—coronary artery disease	1.62e-05	7.3e-05	CcSEcCtD
Paroxetine—CHRM3—Signaling Pathways—APOA1—coronary artery disease	2.32e-06	1.96e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—KDR—coronary artery disease	2.32e-06	1.96e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CD36—coronary artery disease	2.32e-06	1.96e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—KDR—coronary artery disease	2.31e-06	1.95e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	2.3e-06	1.95e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—KDR—coronary artery disease	2.3e-06	1.94e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	2.3e-06	1.94e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAT—coronary artery disease	2.29e-06	1.94e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	2.29e-06	1.94e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.29e-06	1.93e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	2.28e-06	1.93e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—KDR—coronary artery disease	2.28e-06	1.93e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	2.26e-06	1.91e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ESR1—coronary artery disease	2.26e-06	1.91e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	2.25e-06	1.9e-05	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—AKT1—coronary artery disease	2.24e-06	1.9e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	2.24e-06	1.89e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—F2—coronary artery disease	2.23e-06	1.89e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FN1—coronary artery disease	2.23e-06	1.89e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOB—coronary artery disease	2.23e-06	1.88e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CASP3—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—F2—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FN1—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	2.22e-06	1.88e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—F2—coronary artery disease	2.21e-06	1.87e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FN1—coronary artery disease	2.21e-06	1.87e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	2.21e-06	1.87e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—coronary artery disease	2.21e-06	1.87e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	2.21e-06	1.87e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	2.2e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.2e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.2e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—coronary artery disease	2.2e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.2e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	2.19e-06	1.86e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—F2—coronary artery disease	2.19e-06	1.85e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FN1—coronary artery disease	2.19e-06	1.85e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.19e-06	1.85e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	2.19e-06	1.85e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	2.18e-06	1.85e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.18e-06	1.84e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.17e-06	1.84e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	2.17e-06	1.83e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTM1—coronary artery disease	2.16e-06	1.83e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCND1—coronary artery disease	2.16e-06	1.83e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAT—coronary artery disease	2.16e-06	1.83e-05	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	2.15e-06	1.82e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAT—coronary artery disease	2.14e-06	1.81e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—KIT—coronary artery disease	2.14e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CASP3—coronary artery disease	2.13e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—KIT—coronary artery disease	2.13e-06	1.8e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—LPL—coronary artery disease	2.12e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—KIT—coronary artery disease	2.12e-06	1.79e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—coronary artery disease	2.11e-06	1.79e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPARG—coronary artery disease	2.1e-06	1.78e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—coronary artery disease	2.1e-06	1.78e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—coronary artery disease	2.1e-06	1.77e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—KIT—coronary artery disease	2.1e-06	1.77e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOB—coronary artery disease	2.1e-06	1.77e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AGT—coronary artery disease	2.09e-06	1.76e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOB—coronary artery disease	2.08e-06	1.76e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—coronary artery disease	2.07e-06	1.75e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GPX1—coronary artery disease	2.07e-06	1.75e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCND1—coronary artery disease	2.07e-06	1.75e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	2.05e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOE—coronary artery disease	2.04e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.04e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	2.04e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	2.04e-06	1.72e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—coronary artery disease	2.03e-06	1.72e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	2.03e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	2.03e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—coronary artery disease	2.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	2.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOA1—coronary artery disease	2.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CD36—coronary artery disease	2.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—coronary artery disease	2.02e-06	1.7e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	2.02e-06	1.7e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	2.01e-06	1.7e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—coronary artery disease	2.01e-06	1.7e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—LPL—coronary artery disease	2e-06	1.69e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—coronary artery disease	2e-06	1.69e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	2e-06	1.69e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.99e-06	1.69e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	1.99e-06	1.68e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—LPL—coronary artery disease	1.99e-06	1.68e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	1.98e-06	1.68e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	1.98e-06	1.67e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	1.97e-06	1.67e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	1.97e-06	1.67e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	1.97e-06	1.66e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.96e-06	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	1.95e-06	1.65e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GPX1—coronary artery disease	1.95e-06	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	1.95e-06	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	1.95e-06	1.65e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.95e-06	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	1.95e-06	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	1.94e-06	1.64e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GPX1—coronary artery disease	1.94e-06	1.64e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	1.94e-06	1.64e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.94e-06	1.64e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	1.93e-06	1.63e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—coronary artery disease	1.92e-06	1.63e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	1.92e-06	1.62e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTHFR—coronary artery disease	1.91e-06	1.62e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	1.91e-06	1.62e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CD36—coronary artery disease	1.9e-06	1.61e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—coronary artery disease	1.89e-06	1.6e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CD36—coronary artery disease	1.89e-06	1.59e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	1.88e-06	1.59e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.88e-06	1.59e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.86e-06	1.57e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.86e-06	1.57e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.86e-06	1.57e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.85e-06	1.56e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.85e-06	1.56e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.84e-06	1.56e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	1.84e-06	1.56e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.83e-06	1.54e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	1.82e-06	1.54e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AGT—coronary artery disease	1.82e-06	1.54e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—coronary artery disease	1.81e-06	1.53e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	1.81e-06	1.53e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.8e-06	1.52e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.8e-06	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	1.79e-06	1.51e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.79e-06	1.51e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	1.78e-06	1.51e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOE—coronary artery disease	1.78e-06	1.51e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARG—coronary artery disease	1.78e-06	1.51e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.77e-06	1.5e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.77e-06	1.49e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.76e-06	1.49e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOA1—coronary artery disease	1.76e-06	1.49e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	1.76e-06	1.49e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—coronary artery disease	1.76e-06	1.48e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.74e-06	1.47e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	1.73e-06	1.46e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.72e-06	1.46e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.71e-06	1.45e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AGT—coronary artery disease	1.71e-06	1.45e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	1.71e-06	1.44e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AGT—coronary artery disease	1.7e-06	1.44e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	1.7e-06	1.43e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.69e-06	1.43e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.69e-06	1.43e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.68e-06	1.42e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOE—coronary artery disease	1.68e-06	1.42e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.68e-06	1.42e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOE—coronary artery disease	1.66e-06	1.41e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.66e-06	1.4e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.66e-06	1.4e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	1.66e-06	1.4e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.65e-06	1.4e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOA1—coronary artery disease	1.64e-06	1.39e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	1.62e-06	1.37e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—coronary artery disease	1.6e-06	1.35e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.58e-06	1.33e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.57e-06	1.33e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.56e-06	1.32e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	1.56e-06	1.32e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARG—coronary artery disease	1.55e-06	1.31e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.54e-06	1.31e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—coronary artery disease	1.53e-06	1.29e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—coronary artery disease	1.53e-06	1.29e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.52e-06	1.28e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.51e-06	1.28e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	1.51e-06	1.27e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.51e-06	1.27e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.5e-06	1.27e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.5e-06	1.26e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	1.49e-06	1.26e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.49e-06	1.26e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.49e-06	1.26e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.48e-06	1.25e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	1.47e-06	1.24e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.47e-06	1.24e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.47e-06	1.24e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARG—coronary artery disease	1.46e-06	1.24e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.46e-06	1.23e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.45e-06	1.23e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARG—coronary artery disease	1.45e-06	1.23e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—coronary artery disease	1.44e-06	1.22e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.44e-06	1.22e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—coronary artery disease	1.43e-06	1.21e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.42e-06	1.2e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.42e-06	1.2e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	1.41e-06	1.19e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.4e-06	1.18e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.4e-06	1.18e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—coronary artery disease	1.4e-06	1.18e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.38e-06	1.17e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.37e-06	1.16e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.36e-06	1.15e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—coronary artery disease	1.33e-06	1.13e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—coronary artery disease	1.31e-06	1.11e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—coronary artery disease	1.3e-06	1.1e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—coronary artery disease	1.3e-06	1.1e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.28e-06	1.08e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.27e-06	1.07e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.27e-06	1.07e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.26e-06	1.06e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.25e-06	1.06e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—coronary artery disease	1.25e-06	1.06e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—coronary artery disease	1.25e-06	1.05e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—coronary artery disease	1.22e-06	1.03e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—AKT1—coronary artery disease	1.2e-06	1.02e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.18e-06	1e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.17e-06	9.92e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.17e-06	9.86e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.16e-06	9.83e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—AKT1—coronary artery disease	1.15e-06	9.74e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.15e-06	9.74e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.15e-06	9.72e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.15e-06	9.72e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.14e-06	9.67e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.14e-06	9.64e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.14e-06	9.64e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.13e-06	9.55e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.02e-06	8.61e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	9.98e-07	8.44e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	9.93e-07	8.39e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	9.9e-07	8.37e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	9.8e-07	8.28e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—AKT1—coronary artery disease	9.67e-07	8.17e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—coronary artery disease	8.84e-07	7.47e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—coronary artery disease	8.79e-07	7.43e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—coronary artery disease	8.76e-07	7.41e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—coronary artery disease	8.68e-07	7.34e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	8.62e-07	7.29e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—AKT1—coronary artery disease	8.32e-07	7.03e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	8.15e-07	6.89e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	8.11e-07	6.86e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	8.08e-07	6.83e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	8e-07	6.77e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3CA—coronary artery disease	7.51e-07	6.35e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	7.08e-07	5.98e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AKT1—coronary artery disease	7.04e-07	5.95e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	7.01e-07	5.93e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AKT1—coronary artery disease	6.13e-07	5.19e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AKT1—coronary artery disease	5.78e-07	4.89e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AKT1—coronary artery disease	5.73e-07	4.84e-06	CbGpPWpGaD
